Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SafE-OrBi: Switching from Humira to Imraldi in IBD
NCT04045782Phase 4Completed
- Start
- Aug 2019
- Primary completion
- Jan 2021
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 4 trial of adalimumab in Crohn's disease, ulcerative colitis (UC). Started Aug 2019; status: completed.
02
Drugs
03
Conditions
Crohn's diseaseulcerative colitis (UC)
Beyond the preview
Go deeper on NCT04045782.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04045782.